Q1 2022 Rain Therapeutics Inc Earnings Call Transcript
Good afternoon, and welcome to the Rain Therapeutics First Quarter 2022 Earnings Call. (Operator Instructions) Please note this event is being recorded. I would now like to turn the conference over to Bob Yedid of LifeSci Advisors. Please go ahead.
Thank you, operator, and good afternoon, everyone. With me today on the phone are Avanish Vellanki, Chief Executive Officer of Rain Therapeutics; Robert Doebele, Chief Scientific Officer; Richard Bryce, Chief Medical Officer; and Nelson Cabatuan, SVP of Finance. During today's call, Avanish will provide an overall business update. Richard will provide an update on Rain's clinical programs. Bob will review the research efforts. Nelson will review the financials.
Before we begin, I'd like to remind you that the statements made on this conference call that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon Rain's current expectations and involve assumptions that may never
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
